These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


803 related items for PubMed ID: 16221712

  • 1. Chronic allograft nephropathy: expression and localization of PAI-1 and PPAR-gamma.
    Revelo MP, Federspiel C, Helderman H, Fogo AB.
    Nephrol Dial Transplant; 2005 Dec; 20(12):2812-9. PubMed ID: 16221712
    [Abstract] [Full Text] [Related]

  • 2. Comprehensive immunohistological analysis of the endothelin system in human kidney grafts.
    Frank K, Zeier M, Gross ML, Waldherr R, Ritz E, Amann K.
    Nephrol Dial Transplant; 2006 May; 21(5):1365-72. PubMed ID: 16449275
    [Abstract] [Full Text] [Related]

  • 3. Rapamycin inhibits PAI-1 expression and reduces interstitial fibrosis and glomerulosclerosis in chronic allograft nephropathy.
    Pontrelli P, Rossini M, Infante B, Stallone G, Schena A, Loverre A, Ursi M, Verrienti R, Maiorano A, Zaza G, Ranieri E, Gesualdo L, Ditonno P, Bettocchi C, Schena FP, Grandaliano G.
    Transplantation; 2008 Jan 15; 85(1):125-34. PubMed ID: 18192922
    [Abstract] [Full Text] [Related]

  • 4. Rosiglitazone prevents advanced glycation end products-induced renal toxicity likely through suppression of plasminogen activator inhibitor-1.
    Yu X, Li C, Li X, Cai L.
    Toxicol Sci; 2007 Apr 15; 96(2):346-56. PubMed ID: 17264099
    [Abstract] [Full Text] [Related]

  • 5. Fibrosis-associated gene expression in renal transplant glomeruli after acute renal allograft rejection.
    Brook NR, White SA, Waller JR, Bicknell GR, Nicholson ML.
    Br J Surg; 2003 Aug 15; 90(8):1009-14. PubMed ID: 12905557
    [Abstract] [Full Text] [Related]

  • 6. Thromboxane synthase expression in renal transplant patients with rejection.
    Ramos EL, Barri YM, Croker BP, Clapp WL, Peterson JC, Wilcox CS.
    Transplantation; 1995 Feb 27; 59(4):490-4. PubMed ID: 7878751
    [Abstract] [Full Text] [Related]

  • 7. Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats.
    Ma LJ, Marcantoni C, Linton MF, Fazio S, Fogo AB.
    Kidney Int; 2001 May 27; 59(5):1899-910. PubMed ID: 11318962
    [Abstract] [Full Text] [Related]

  • 8. Epidermal growth factor receptor expression in human renal allograft biopsies: an immunohistochemical study.
    Sis B, Sarioglu S, Celik A, Zeybel M, Soylu A, Bora S.
    Transpl Immunol; 2004 Nov 27; 13(3):229-32. PubMed ID: 15381206
    [Abstract] [Full Text] [Related]

  • 9. Can histopathological findings in early renal allograft biopsies identify patients at risk for chronic vascular rejection?
    Dimény E, Wahlberg J, Larsson E, Fellström B.
    Clin Transplant; 1995 Apr 27; 9(2):79-84. PubMed ID: 7599406
    [Abstract] [Full Text] [Related]

  • 10. Recurrence of IgA nephropathy with crescents in kidney transplants.
    Mousson C, Charon-Barra C, Funes de la Vega M, Tanter Y, Justrabo E, Martin L, Rifle G.
    Transplant Proc; 2007 Oct 27; 39(8):2595-6. PubMed ID: 17954186
    [Abstract] [Full Text] [Related]

  • 11. Focal and segmental glomerulosclerosis in renal allograft recipients: a clinico-pathologic study of 37 cases.
    Gupta R, Sharma A, Mahanta PJ, Agarwal SK, Dinda AK.
    Saudi J Kidney Dis Transpl; 2013 Jan 27; 24(1):8-14. PubMed ID: 23354185
    [Abstract] [Full Text] [Related]

  • 12. Gene expression of plasminogen activator inhibitor 1 in transplant kidneys complicated by renal vein thrombosis: a combined study by in-situ hybridization and immunohistochemistry.
    Wang Y, Turner N, An SF, Fleming KA, Thompson EM.
    Nephrol Dial Transplant; 1994 Jan 27; 9(3):296-303. PubMed ID: 8052438
    [Abstract] [Full Text] [Related]

  • 13. Comparison of renal allograft fibrosis after transplantation from heart-beating and non-heart-beating donors.
    Bains JC, Sandford RM, Brook NR, Hosgood SA, Lewis GR, Nicholson ML.
    Br J Surg; 2005 Jan 27; 92(1):113-8. PubMed ID: 15593295
    [Abstract] [Full Text] [Related]

  • 14. Clinicopathologic analysis of renal biopsies after haematopoietic stem cell transplantation.
    Chan GS, Lam MF, Au WY, Chim S, Tse KC, Lo SH, Fung SH, Lai KN, Chan KW.
    Nephrology (Carlton); 2008 Jun 27; 13(4):322-30. PubMed ID: 18221254
    [Abstract] [Full Text] [Related]

  • 15. Ultrastructural analysis of the Fisher to Lewis rat model of chronic allograft nephropathy.
    Hamar P, Lipták P, Heemann U, Iványi B.
    Transpl Int; 2005 Jul 27; 18(7):863-70. PubMed ID: 15948867
    [Abstract] [Full Text] [Related]

  • 16. Focal segmental glomerulosclerosis in renal allografts with chronic nephropathy: implications for graft survival.
    Cosio FG, Frankel WL, Pelletier RP, Pesavento TE, Henry ML, Ferguson RM.
    Am J Kidney Dis; 1999 Oct 27; 34(4):731-8. PubMed ID: 10516356
    [Abstract] [Full Text] [Related]

  • 17. Prediction of chronic allograft damage index of renal allografts using serum level of plasminogen activator inhibitor-1.
    Chang HR, Yang SF, Lian JD, Lin CC, Wen MC, Chen YT, Jan YJ, Hsieh YS.
    Clin Transplant; 2009 Oct 27; 23(2):206-12. PubMed ID: 19220364
    [Abstract] [Full Text] [Related]

  • 18. Expression of the chemokine receptor CXCR3 in human renal allografts--a prospective study.
    Hoffmann U, Segerer S, Rümmele P, Krüger B, Pietrzyk M, Hofstädter F, Banas B, Krämer BK.
    Nephrol Dial Transplant; 2006 May 27; 21(5):1373-81. PubMed ID: 16421159
    [Abstract] [Full Text] [Related]

  • 19. The natural history of chronic allograft nephropathy.
    Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR.
    N Engl J Med; 2003 Dec 11; 349(24):2326-33. PubMed ID: 14668458
    [Abstract] [Full Text] [Related]

  • 20. Cigarette smoking and chronic allograft nephropathy.
    Zitt N, Kollerits B, Neyer U, Mark W, Heininger D, Mayer G, Kronenberg F, Lhotta K.
    Nephrol Dial Transplant; 2007 Oct 11; 22(10):3034-9. PubMed ID: 17517794
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 41.